Abstract
The immunoassay assay is undergoing a major makeover. New amplification
methods offer the promise to peer deeper into the proteome; new detection
methods offer the promise to see clearer; new multiplexing to look faster and
more efficiently; and new content to observe farther. These new technologies
are addressing significant unmet needs in sensitivity, accuracy, speed, cost
and breadth.
This new report details the opportunities and challenges in a market valued at
more than $1.1 billion in 2003 and projected to grow to more than $2.2 billion
in 2012. The report is based on surveys of researchers and thorough
evaluations of more than 70 technologies encompassing novel antibody
generation, real-time detection, new amplification methods and multiplexed
antibody arrays. The financial projections are based on a 3 by 5 market matrix
model encompassing instruments, antibodies and other reagents and consumables
across ELISAs, Western blots, immunoprecipitations, antibody arrays and novel
antibody characterization methods.
In addition, the report comes with an hour of discussion (pending availability
and limited to a conference call format) with Steven Bodovitz, Principal of
BioPerspectives, or Jutta Bachmann, CEO of Bachmann Consulting.
View Cart
